Redmile Group, LLC - 10%+ Owner at Entrada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
TRDA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Redmile Group, LLC since 09 Jan 2025

Holdings reported by Redmile Group, LLC for Entrada Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,954,420 $31,251,176 $15.99 02 Nov 2021 Indirect
Series B Convertible Preferred Stock 0 02 Nov 2021 Indirect Common Stock

Transactions reported by Redmile Group, LLC for Entrada Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.